Your browser doesn't support javascript.
loading
Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies.
Julián-Serrano, Sachelly; Yuan, Fangcheng; Wheeler, William; Benyamin, Beben; Machiela, Mitchell J; Arslan, Alan A; Beane-Freeman, Laura E; Bracci, Paige M; Duell, Eric J; Du, Mengmeng; Gallinger, Steven; Giles, Graham G; Goodman, Phyllis J; Kooperberg, Charles; Marchand, Loic Le; Neale, Rachel E; Shu, Xiao-Ou; Van Den Eeden, Stephen K; Visvanathan, Kala; Zheng, Wei; Albanes, Demetrius; Andreotti, Gabriella; Ardanaz, Eva; Babic, Ana; Berndt, Sonja I; Brais, Lauren K; Brennan, Paul; Bueno-de-Mesquita, Bas; Buring, Julie E; Chanock, Stephen J; Childs, Erica J; Chung, Charles C; Fabiánová, Eleonora; Foretová, Lenka; Fuchs, Charles S; Gaziano, J Michael; Gentiluomo, Manuel; Giovannucci, Edward L; Goggins, Michael G; Hackert, Thilo; Hartge, Patricia; Hassan, Manal M; Holcátová, Ivana; Holly, Elizabeth A; Hung, Rayjean I; Janout, Vladimir; Kurtz, Robert C; Lee, I-Min; Malats, Núria; McKean, David.
Affiliation
  • Julián-Serrano S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Yuan F; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Wheeler W; Information Management Services, Silver Spring, MD, USA.
  • Benyamin B; Australian Centre for Precision Health, Allied Health and Human Performance, University of South Australia, Adelaide, Australia.
  • Machiela MJ; South Australian Health and Medical Research Institute, Adelaide, Australia.
  • Arslan AA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Beane-Freeman LE; Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY, USA.
  • Bracci PM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Duell EJ; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
  • Du M; Unit of Biomarkers and Susceptibility, Oncology Data Analytics Program, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Gallinger S; Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Giles GG; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Goodman PJ; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Kooperberg C; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Canada.
  • Marchand LL; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
  • Neale RE; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
  • Shu XO; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia.
  • Van Den Eeden SK; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Visvanathan K; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Zheng W; Department of Epidemiology, University of Hawaii Cancer Center, Honolulu, HI, USA.
  • Albanes D; Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
  • Andreotti G; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Ardanaz E; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
  • Babic A; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Berndt SI; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Brais LK; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Brennan P; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Bueno-de-Mesquita B; Navarra Public Health Institute, Pamplona, Spain.
  • Buring JE; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
  • Chanock SJ; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
  • Childs EJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Chung CC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Fabiánová E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Foretová L; International Agency for Research on Cancer (IARC), Lyon, France.
  • Fuchs CS; Department for Determinants of Chronic Diseases, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
  • Gaziano JM; Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Gentiluomo M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Giovannucci EL; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
  • Goggins MG; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Hackert T; Specialized Institute of Hygiene and Epidemiology, Banska Bystrica, Slovakia.
  • Hartge P; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Hassan MM; Yale Cancer Center and Smilow Cancer Hospital, New Haven, CT, USA.
  • Holcátová I; Division of Aging, Brigham and Women's Hospital, Boston, MA, USA.
  • Holly EA; Department of Biology, University of Pisa, Italy.
  • Hung RI; Genomic Epidemiology Group, German Cancer Research Center, (DKFZ), Heidelberg, Germany.
  • Janout V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Kurtz RC; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Lee IM; Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Malats N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • McKean D; Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Am J Clin Nutr ; 114(4): 1408-1417, 2021 10 04.
Article in En | MEDLINE | ID: mdl-34258619
ABSTRACT

BACKGROUND:

Epidemiological studies have suggested positive associations for iron and red meat intake with risk of pancreatic ductal adenocarcinoma (PDAC). Inherited pathogenic variants in genes involved in the hepcidin-regulating iron metabolism pathway are known to cause iron overload and hemochromatosis.

OBJECTIVES:

The objective of this study was to determine whether common genetic variation in the hepcidin-regulating iron metabolism pathway is associated with PDAC.

METHODS:

We conducted a pathway analysis of the hepcidin-regulating genes using single nucleotide polymorphism (SNP) summary statistics generated from 4 genome-wide association studies in 2 large consortium studies using the summary data-based adaptive rank truncated product method. Our population consisted of 9253 PDAC cases and 12,525 controls of European descent. Our analysis included 11 hepcidin-regulating genes [bone morphogenetic protein 2 (BMP2), bone morphogenetic protein 6 (BMP6), ferritin heavy chain 1 (FTH1), ferritin light chain (FTL), hepcidin (HAMP), homeostatic iron regulator (HFE), hemojuvelin (HJV), nuclear factor erythroid 2-related factor 2 (NRF2), ferroportin 1 (SLC40A1), transferrin receptor 1 (TFR1), and transferrin receptor 2 (TFR2)] and their surrounding genomic regions (±20 kb) for a total of 412 SNPs.

RESULTS:

The hepcidin-regulating gene pathway was significantly associated with PDAC (P = 0.002), with the HJV, TFR2, TFR1, BMP6, and HAMP genes contributing the most to the association.

CONCLUSIONS:

Our results support that genetic susceptibility related to the hepcidin-regulating gene pathway is associated with PDAC risk and suggest a potential role of iron metabolism in pancreatic carcinogenesis. Further studies are needed to evaluate effect modification by intake of iron-rich foods on this association.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Gene Expression Regulation, Neoplastic / Hepcidins / Iron Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Clin Nutr Year: 2021 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Gene Expression Regulation, Neoplastic / Hepcidins / Iron Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Clin Nutr Year: 2021 Document type: Article Affiliation country: Estados Unidos